Elanco Animal Health Inc [ELAN] stock is trading at $17.1, up 2.58%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ELAN shares have gain 21.54% over the last week, with a monthly amount glided 14.77%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Elanco Animal Health Inc [NYSE: ELAN] stock has seen the most recent analyst activity on July 17, 2025, when Leerink Partners upgraded its rating to a Outperform but kept the price target unchanged to $18 for it. Previously, William Blair upgraded its rating to Outperform on June 26, 2025. On December 09, 2024, UBS initiated with a Buy rating and assigned a price target of $18 on the stock. Leerink Partners started tracking the stock assigning a Market Perform rating and suggested a price target of $14 on December 02, 2024. Morgan Stanley downgraded its rating to a Equal-Weight and reduced its price target to $15 on September 19, 2024. Stifel upgraded its rating to Buy for this stock on January 05, 2024, and upped its price target to $20. In a note dated December 19, 2023, Jefferies initiated an Buy rating and provided a target price of $17 on this stock.
Elanco Animal Health Inc [ELAN] stock has fluctuated between $8.02 and $16.70 over the past year. Currently, Wall Street analysts expect the stock to reach $19 within the next 12 months. Elanco Animal Health Inc [NYSE: ELAN] shares were valued at $17.1 at the most recent close of the market. An investor can expect a potential return of 11.11% based on the average ELAN price forecast.
Analyzing the ELAN fundamentals
Elanco Animal Health Inc [NYSE:ELAN] reported sales of 4.48B for the trailing twelve months, which represents a growth of 4.81%. Gross Profit Margin for this corporation currently stands at 0.49% with Operating Profit Margin at 0.08%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.1%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.07 and Total Capital is 0.03. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.62.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 16.90 points at the first support level, and at 16.69 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.30, and for the 2nd resistance point, it is at 17.49.
Ratios To Look Out For
For context, Elanco Animal Health Inc’s Current Ratio is 2.60. Also, the Quick Ratio is 1.40, while the Cash Ratio stands at 0.39. Considering the valuation of this stock, the price to sales ratio is 1.89, the price to book ratio is 1.25 and price to earnings (TTM) ratio is 19.59.
Transactions by insiders
Recent insider trading involved Todd S and Jennifer G Young Li, Former CFO, that happened on Aug 11 ’25 when 49333.0 shares were purchased. Director, Kurzius Lawrence Erik completed a deal on Mar 07 ’25 to buy 10000.0 shares. Meanwhile, Director Kurzius Lawrence Erik bought 10000.0 shares on Mar 11 ’25.
